Alison E. Freimund
305 Grattan Street
Melbourne, VIC 3000, Australia
Melbourne, VIC 3000, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Treatment patterns after poly-ADP ribose polymerase (PARP) inhibitors in epithelial ovarian cancer patients.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: March 24, 2022
Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 13, 2022
ENhAncing Lifestyle Behaviors in EndometriaL CancEr (ENABLE): A Pilot Randomized Controlled Trial.
Journal: Integrative cancer therapies
Published: January 20, 2022
Cancer Diagnoses Following Abnormal Noninvasive Prenatal Testing: A Case Series, Literature Review, and Proposed Management Model.
Journal: JCO precision oncology
Published: January 07, 2022
Clinical Utility of Real-Time Targeted Molecular Profiling in the Clinical Management of Ovarian Cancer: The ALLOCATE Study.
Journal: JCO precision oncology
Published: December 01, 2019
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial.
Journal: The Lancet. Oncology
Published: March 18, 2019
Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer.
Journal: Hematology/oncology clinics of North America
Published: November 05, 2018
Improvement of Outcomes for Women With HIV Infection and Cervical Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 31, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026